Galezowski A, Maccari F, Hadj-Rabia S, Sigal ML, Phan A, Lahfa M, Bursztejn AC, Barthélémy H, Boralevi F, Reguiai Z, Chiavérini C, Estève E, Bourrat E, Ruer-Mulard M, Beauchet A, Mahé E, pour le GEM Resopso et le Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Rhumatisme psoriasique en France, du nourrisson à la personne âgée : données de deux études transversales multicentriques. Annales de Dermatologie et Vénéréologie2018;145:13-20.
Bégon E, Beneton N, Poiraud C, Droitcourt C, Jacobzone C, Vermersch A, Descamps V, Perrot JL, Khemis A, Pallure V, Fougerousse AC, Sigal ML, Schmutz JL, Goujon C, Reguiaï Z. Safety and efficacy of biologic therapies in psoriatic patients with alcoholic cirrhosis: a French retrospective study of 23 cases. British Journal of Dermatology 2018 (Epub ahead of print)
Grodner C, Kluger N, Fougerousse AC, Cinotti E, Lacarrubba F, Beauchet A, Quiles-Tsimaratos N, Mahé E, for the GEM Resopso. Tattooing and psoriasis: dermatologists’ knowledge, attitudes and practices. An international study. Journal of the European Academy of Dermatology and Venereology 2018 (Epub ahead of print)
Dabouz F, Khemis A, Barbe C, Lahfa M, Maccari F, Chaby G, Beneton N, Boye T, Esteve E, Mahé E, Begon E, Pauwels C, Bernard P, Reguiai Z, on behalf of Resopso network. Factors associated with successful switching between biologic therapies for the treatment of psoriasis in daily dermatological real-life practice: The Resoswitch study. Dermatologic Therapies 2018;
Méry-Bossard L, Bagny K, Chaby G, Khemis A, Maccari F, Marotte H, Perrot JL, Reguiai Z, Sigal ML, Avenel-Audran M, Boyé T, Grasland A, Gillard J, Jullien D, Toussirot E. New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases. Journal of the European Academy of Dermatology and Venereology 2017;31;181-186.
Amy de la Bretèque M, Sigal ML, Reguiai Z, Maccari F, Ruer-Mulard M, Le Guyadec T, Estève E, Goujon-Henry C, Chaby G, Barthélémy H, Parier J, Steiner HG, Bégon E, Maillard H, Bastien M, Beauchet A, Mahé E, and the GEM Resopso.Characteristics of patients with plaque psoriasis who have discordance between PASI and DLQI scores. Journal of the European Academy of Dermatology and Venereology 2017;31:e269-e272.
Mahé E, Beauchet A, Reguiaï Z, Maccari F, Ruer-Mulard M, Chaby G, Le Guyadec T, Estève E, Goujon-Henry C, Parier J, Barthelemy H, Bégon E, Steiner HG, Beneton N, Boyé T, Mery-Bossard L, Schmutz JL, Bravard P, Sigal ML, and the GEM Resopso.Socioeconomic inequalities and severity of plaque psoriasis at a first consultation in dermatology centers. Acta Dermato-Venereologica 2017;97:632-638.
Bonigen J, Raynaud C, Hureaux J, Kramkimel N, Blom A, Jeudy G, Breton AL, Hubiche T, Bedane C, Legoupil D, Pham-Ledard A, Pérol M, Gérard E, Combemale P, Bonnet D, Sigal ML, Mahé E, for the Groupe de Recherche sur le Psoriasis and the Groupe Cancérologie Cutanée of the Société Française de Dermatologie, theGEM Resopso, Apsoderm, the CEDEF, and the Groupe Français de Pneumo-Cancérologie.Anti-PD1-
Mahé E, Maccari F, Beauchet A, Quiles-Tsimaratos N, Beneton N, Parier J, Barthelemy H, Goujon-Henry C, Chaby G, Thomas-Beaulieu D, Géner G, Wagner L, Pallure V, Devaux S, Vermersch-Langlin A, Pfister P, Jégou J, Livideanu C, Sigal ML, pour le GEM Resopso.Patients atteints de psoriasis : analyse de la population insatisfaite de sa prise en charge. Annales de Dermatologie et Vénéréologie 2017;144:497-507.
Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis.
Phan C, Sigal ML, Estève E, Reguiai Z, Barthélémy H, Bénéton N, Maccari F, Lahfa M, Thomas-Beaulieu D, Le Guyadec T, Vermersch-Langlin A, Mery-Bossard L, Pallure V, Kemula M, Labeille B, Beauchet A, Mahé E, and the GEM RESOPSO. Journal of the European Academy of Dermatology and Venereology 2016;30:78-82.
Development of monoclonal gammapathy under biotherapy in psoriasis: French multicenter retrospective study.
Liégeon AL, Mahé E, Bégon E, Poreaux C, Barbaux A, Estève E, Quiles-Tsimaratos N, Avenel-Audran M, Schoeffler A, Mery-Bossard L, Pauwels C, Girard C, Maillard H, Barthelme D, Bernier C, Chaby G, Reguiai Z, Nguyen-Thi PL, Maccari F, Schmutz JL. European Journal of Dermatology 2016;26:75-81.
Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.
Phan C, Sigal ML, Lhafa M, Barthélémy H, Maccari F, Estève E, Reguiai Z, Perrot JL, Chaby G, Maillard H, Bégon E, Alexandre M, Toussaint P, Bastien-Jacquin M, Bravard P, Sauque E, De Quatrebarbes J, Pfister P, Beauchet A, Mahé E, et le GEM Resopso. Annales de Dermatologie et Vénéréologie 2016;143:264-74.
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
Mahé E, Reguiai Z, Barthelemy H, Quiles-Tsimaratos N, Chaby G, Girard C, Estève E, Maccari F, Descamps V, Schmutz JL, Bégon E, Bravard P, Maillard H, Boyer T, Beauchet A, Sigal ML, for the GEM Resopso. Journal of the European Academy of Dermatology and Venereology 2014;28:151-9.
Descamps V, Mahé E, Maccari F, Begon E, Barthelemy H, Reguiai Z, Bénéton N, Estève E, Chaby G, Ruer-Mulard M, Steiner HG, Thomas-Beaulieu D, Avenel-Audran M, Goujon-Henry C, Sigal ML, Ezzedine K, Beauchet A. European Journal of Dermatology2014;24:356-60.
Childhood onset psoriasis: association with future cardiovascular and metabolic comorbidities.
Mahé E, Maccari F, Beauchet A, Lahfa M, Barthelemy H, Reguiaï Z, Beneton N, Estève E, Chaby G, Ruer-Mulard M, Steiner HG, Pauwels C, Avenel-Audran M, Goujon-Henry C, Descamps V, Bégon E, Sigal ML, for the GEM Resopso. British Journal of Dermatology2013;169:889-95.